Fort, L.P. Amgen Inc Transaction History

Fort, L.P.

$38.5 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $66,948 - $80,815	-249 Reduced 21.78%	894 $254,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $2,623 - $3,257	-12 Reduced 1.04%	1,143 $307,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $13,070 - $15,455	-61 Reduced 5.02%	1,155 $256,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $112,443 - $137,049	-498 Reduced 29.05%	1,216 $293,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $140,395 - $178,389	-613 Reduced 26.34%	1,714 $450,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $355,544 - $400,989	-1,584 Reduced 40.5%	2,327 $525,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $546,321 - $607,960	-2,368 Reduced 37.71%	3,911 $952,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $54,598 - $60,399	-249 Reduced 3.81%	6,279 $1.52 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $34,406 - $39,374	173 Added 2.72%	6,528 $1.47 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $80,025 - $93,759	-377 Reduced 5.6%	6,355 $1.35 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $90,161 - $100,028	-386 Reduced 5.42%	6,732 $1.64 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $78,112 - $91,027	352 Added 5.2%	7,118 $1.77 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $336,903 - $401,192	1,557 Added 29.89%	6,766 $1.56 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $120,140 - $133,606	512 Added 10.9%	5,209 $1.32 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $1.69 Million - $2.07 Million	-8,547 Reduced 64.53%	4,697 $1.11 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $29,158 - $38,672	-160 Reduced 1.19%	13,244 $2.69 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $18,542 - $23,833	98 Added 0.74%	13,404 $3.23 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $100,635 - $120,582	578 Added 4.54%	13,306 $2.58 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $211,375 - $247,779	1,268 Added 11.06%	12,728 $2.35 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $525,427 - $592,271	2,905 Added 33.96%	11,460 $2.18 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $155,564 - $181,594	-872 Reduced 9.25%	8,555 $1.67 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $1.38 Million - $1.56 Million	-7,456 Reduced 44.16%	9,427 $1.95 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $4.14 Million - $4.65 Million	-24,946 Reduced 59.64%	16,883 $3.12 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $405,445 - $473,814	-2,393 Reduced 5.41%	41,829 $7.13 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $1.06 Million - $1.18 Million	6,256 Added 16.48%	44,222 $7.69 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $6.35 Million - $7.25 Million	37,966	37,966 $7.08 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.

Account